Antidepressants are currently the treatment of choice for major depressive disorder (MDD). Nevertheless, a high percentage of patients do not respond to a first-line antidepressant drug, and combination treatments and augmentation strategies increase the risk of side effects. Moreover, a significant proportion of patients are treatment-resistant. In the last 30 years, a number of studies have sought to establish whether exercise could be regarded as an alternative to antidepressants, but so far no specific analysis has examined the efficacy of exercise as an adjunctive treatment in combination with antidepressants. We carried out a systematic review to evaluate the effectiveness of exercise as an adjunctive treatment with antidepressants on depression.

A search of relevant papers was carried out in PubMed/Medline, Google Scholar, and Scopus with the following keywords: “exercise,” “physical activity,” “physical fitness,” “depressive disorder,” “depression,” “depressive symptoms,” “add-on,” “augmentation,” “adjunction,” and “combined therapy.” Twenty-two full-text articles were retrieved by the search. Among the 13 papers that fulfilled our inclusion criteria, we found methodological weaknesses in the majority. However, the included studies showed a strong effectiveness of exercise combined with antidepressants.

Further analyses and higher quality studies are needed; nevertheless, as we have focused on a particular intervention (exercise in adjunction to antidepressants) that better reflects clinical practice, we can hypothesize that this strategy could be appropriately and safely translated into real-world practice.

1.Murray, CJ, Vos, T, Lozano, R, etal. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859): 2197–2223.Google Scholar

2.Mathers, CD, Loncar, D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11): 2011–2030.Google Scholar

3.Hollon, SD, Thase, ME, Markowitz, JC. Treatment and prevention of depression. Psychol Sci Public Interest. 2002; 3(2): 39–77.Google Scholar

4.Gasquet, I, Nègre-Pagès, L, Fourrier, A, etal. Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study. Encephale. 2005; 31(2): 195–206.Google Scholar

5.Carta, MG, Aguglia, E, Bocchetta, A, etal. The use of antidepressant drugs and the lifetime prevalence of major depressive disorders in Italy. Clin Pract Epidemiol Ment Health. 2010; 6: 94–100.Google Scholar

6.Hamer, M, Batty, GD, Seldenrijk, A, Kivimaki, M. Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey. Eur Heart J. 2011; 32(4): 437–442.Google Scholar

7.Olfson, M, Marcus, SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009; 66(8): 848–856.Google Scholar

8.Gartlehner, G, Hansen, RA, Thieda, P , etal. Comparative Effectiveness of Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression. Comparative Effectiveness Reviews, No. 7. AHRQ Publication No. 07-EHC007-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2007. http://www.ncbi.nlm.nih.gov/books/NBK43023/.Google Scholar

9.Trivedi, MH, Rush, AJ, Wisniewski, SR, etal. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006; 163: 28–40.Google Scholar

10.Rush, AJ, Trivedi, MH, Wisniewski, SR, etal. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006; 163(11): 1905–1917.CrossRefGoogle ScholarPubMed

11.Thase, M, Howland, R, Friedman, E. Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry. 1998; 59(Suppl 5): 5–12.Google Scholar

12.Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice. Prescrire Int. 2011; 20: 128–133. [No authors listed].Google Scholar

13.Al-Harbi, KS. Treatment-resistant depression: therapeutic trends, challenges and future directions. Patient Prefer Adherence. 2012; 6: 369–388.Google Scholar

14.Blumenthal, JA, Emery, CF, Madden, DJ, etal. Cardiovascular and behavioral effects of aerobic exercise training in healthy older men and women. J Gerontol. 1989; 44: M147–157.Google Scholar

15.DiLorenzo, TM, Bargman, EP, Stucky-Ropp, R, etal. Long-term effects of aerobic exercise on psychological outcomes. Prev Med. 1999; 28(1): 75–85.Google Scholar

16.Roth, DL, Holmes, DS. Influence of aerobic exercise training and relaxation training on physical and psychologic health following stressful life events. Psychosom Med. 1987; 49: 355–365.Google Scholar

17.King, AC, Taylor, CB, Haskell, WL. Effects of differing intensities and formats of 12 months of exercise training on psychological outcomes in older adults. Health Psychol. 1993; 12(4): 292–300.Google Scholar

18.Klein, MH, Greist, JH, Gurman, AS, Neiberyer, DP. A comparative outcome study of group psychotherapy vs. exercise treatments for depression. International Journal of Mental Health. 1985; 13(3–4): 148–177.Google Scholar

19.Dunn, AL, Trivedi, MH, Kempert, JB, Clark, CG, Chambliss, OH. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005; 28(1): 1–8.Google Scholar

20.Singh, NA, Stavrinos, TM, Scarbek, Y, etal. A randomized controlled trial of high versus low intensity weight training versus general practitioner care for clinical depression in older adults. J Gerontol A Biol Sci Med Sci. 2005; 60(6): 768–776.Google Scholar

21.McNeil, JK, LeBlanc, EM, Joyner, M. The effect of exercise on depressive symptoms in the moderately depressed elderly. Psychol Aging. 1991; 6(3): 487–488.Google Scholar

22.Singh, NA, Clements, KM, Singh, MA. The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized, controlled trial. J Gerontol A Biol Sci Med Sci. 2001; 56(8): M497–504.Google Scholar

23.Goodwin, VA, Richards, SH, Taylor, RS, Taylor, AH, Campbell, JL. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord. 2008; 23(5): 631–640.. Aging Ment Health. 2008; 12(1): 72–80.. Journal of Isfahan Medical School. 2013; 30(212): 1861–1865. [In Persian].'="" href="https://scholar.google.com/scholar_lookup?title=Effects+of+group+exercise+on+women%27s+depressive+symptoms&author=Rashidi+Z&author=Rashidi+A&author=Rouzbahani+R&author=Rezaei+F&publication+year=2013&journal=Journal+of+Isfahan+Medical+School&volume=30&pages=1861-1865">Google Scholar

61.Schuch, FB, Vasconcelos-Moreno, MP, Borowsky, C, Fleck, MP. Exercise and severe depression: preliminary results of an add-on study. J Affect Disord. 2011; 133(3): 615–618.Google Scholar

62.Veale, D, Le Fevre, K, Pantelis, C, etal. Aerobic exercise in the adjunctive treatment of depression: a randomized controlled trial. J R Soc Med. 1992; 85(9): 541–544.Google Scholar

63.de la Cerda, P, Cervelló, E, Cocca, A, Viciana, J. Effect of an aerobic training program as complementary therapy in patients with moderate depression. Percept Mot Skills. 2011; 112(3): 761–769.Google Scholar

64.Deslandes, AC, Moraes, H, Alves, H, etal. Effect of aerobic training on EEG alpha asymmetry and depressive symptoms in the elderly: a 1-year follow-up study. Braz J Med Biol Res. 2010; 43(6): 585–592.Google Scholar

65.Mota-Pereira, J, Carvalho, S, Silverio, J, etal. Moderate physical exercise and quality of life in patients with treatment-resistant major depressive disorder. J Psychiatr Res. 2011; 45(12): 1657–1659.Google Scholar

66.Brenes, GA, Williamson, JD, Messier, SP, etal. Treatment of minor depression in older adults: a pilot study comparing sertraline and exercise. Aging Ment Health. 2007; 11(1): 61–68.Google Scholar

67.Singh, NA, Clements, KM, Fiatarone, MA. A randomized controlled trial of progressive resistance training in depressed elders. J Gerontol A Biol Sci Med Sci. 1997; 52(1): M27–35.Google Scholar

68.Rush, AJ, Golden, WE, Hall, GW, etalDepression in Primary Care, Vol. 1: Detection and Diagnosis. Clinical Practice Guideline, Number 5. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.Google Scholar

69.Rush, AJ, Golden, WE, Hall, GW, etal. Depression in Primary Care, Vol. 2: Treatment of Major Depression. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.Google Scholar

70.Callaghan, P, Khalil, E, Morres, I, Carter, I. Pragmatic randomised controlled trial of preferred intensity exercise in women living with depression. BMC Public Health. 2011; 11: 465.Google Scholar

71.Rutherford, BR, Mori, S, Sneed, JR, Pimontel, MA, Roose, SP. Contribution of spontaneous improvement to placebo response in depression: a meta-analytic review. J Psychiatr Res. 2012; 46(6): 697–702.Google Scholar

72.Iovieno, N, Papakostas, GI. Correlation between different levels of placebo response rate and clinical trial outcome in major depressive disorder: a meta-analysis. J Clin Psychiatry. 2012; 73(10): 1300–1306.Google Scholar

73.Mota-Pereira, J, Silverio, J, Carvalho, S, Ramos, J, Ribeiro, JC. Physical exercise and major depressive disorder—where do we stand? Curr Psychopharmacol. 2012; 1(2): 167–177.CrossRefGoogle Scholar

74.Chalder, M, Wiles, NJ, Campbell, J, etal. Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ. 2012; 344: e2758.Google Scholar

75.Neto, FL, Borges, G, Torres-Sanchez, S, Mico, JA, Berrocoso, E. Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol. 2011; 9(4): 530–552.Google Scholar

76.Mendez-David, I, Hen, R, Gardier, AM, David, DJ. Adult hippocampal neurogenesis: an actor in the antidepressant-like action. Ann Pharm Fr. 2013; 71(3): 143–149.Google Scholar

77.Tanti, A, Belzung, C. Hippocampal neurogenesis: a biomarker for depression or antidepressant effects? Methodological considerations and perspectives for future research. Cell Tissue Res. 2013; 354(1): 203–219.Google Scholar

78.De Foubert, G, Carney, SL, Robinson, CS, etal. Fluoxetine-induced change in rat brain expression of brain-derived neurotrophic factor varies depending on length of treatment. Neuroscience. 2004; 128(3): 597–604.Google Scholar

79.Coppell, AL, Pei, Q, Zetterstrom, TS. Bi-phasic change in BDNF gene expression following antidepressant drug treatment. Neuropharmacology. 2003; 44(7): 903–910.Google Scholar

80.Russo-Neustadt, AA, Alejandre, H, Garcia, C, Ivy, AS, Chen, MJ. Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise. Neuropsychopharmacology. 2004; 29(12): 2189–2199.Google Scholar

81.Czubak, A, Nowakowska, E, Kus, K, etal. Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacol Rep. 2009; 61(6): 1017–1023.Google Scholar

82.Nibuya, M, Morinobu, S, Duman, RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 1995; 15(11): 7539–7547.Google Scholar

83.Altar, CA, Whitehead, RE, Chen, R, Wortwein, G, Madsen, TM. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry. 2003; 54(7): 703–709.Google Scholar

84.Neeper, SA, Gomez-Pinilla, F, Choi, J, Cotman, CW. Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res. 1996; 726(1–2): 49–56.Google Scholar

85.Russo-Neustadt, A, Beard, RC, Cotman, CW. Exercise, anti-depressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology. 1999; 21(5): 679–682.Google Scholar

86.Adlard, PA, Perreau, VM, Engesser-Cesar, C, Cotman, CW. The timecourse of induction of brain-derived neurotrophic factor mRNA and protein in the rat hippocampus following voluntary exercise. Neurosci Lett. 2004; 363(1): 43–48.Google Scholar

87.Arunrut, T, Alejandre, H, Chen, M, Cha, J, Russo-Neustadt, A. Differential behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test. Life Sci. 2009; 84(17–18): 584–589.Google Scholar

88.Russo-Neustadt, A, Ha, T, Ramirez, R, Kesslak, JP. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behav Brain Res. 2001; 120(1): 87–95.Google Scholar

89.Garza, AA, Ha, TG, Garcia, C, Chen, MJ, Russo-Neustadt, AA. Exercise, antidepressant treatment, and BDNF mRNA expression in the aging brain. Pharmacol Biochem Behav. 2004; 77(2): 209–220.Google Scholar

90.Branchi, I, Santarelli, S, Capoccia, S, etal. Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice. PLoS One. 2013; 8(4): e62226.Google Scholar

91.Josefsson, T, Lindwall, M, Archer, T. Physical exercise intervention in depressive disorders: meta-analysis and systematic review. Scand J Med Sci Sports. In press. DOI: 10.1111/sms.12050.Google Scholar

92.Silveira, H, Moraes, H, Oliveira, N, etal. Physical exercise and clinically depressed patients: a systematic review and meta-analysis. Neuropsychobiology. 2013; 67(2): 61–68.Google Scholar

93.Danielsson, L, Noras, AM, Waern, M, Carlsson, J. Exercise in the treatment of major depression: a systematic review grading the quality of evidence. Physiother Theory Pract. 2013; 29(8): 573–585.Google Scholar

94.Craft, LL, Landers, DM. The effect of exercise on clinical depression and depression resulting from mental illness: a meta-analysis. J Sport Exerc Psychol. 1998; 20(4): 339–357.Google Scholar

95.North, TC, McCullagh, P, Tran, ZV. Effect of exercise on depression. Exerc Sport Sci Rev. 1990; 18: 379–415.Google Scholar